Urocortin 2 suppresses host resistance to Listeria monocytogenes infection via up-regulation of interleukin-10

Endocrinology

Volumn 146, Issue 11, 2005, Pages 5003-5011

  Sashinami, Hiroshi ^a   Kageyama, Kazunori ^a   Suda, Toshihiro ^a   Nakane, Akio ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; GAMMA INTERFERON; INTERLEUKIN 10; MONOCLONAL ANTIBODY; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN II;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; HOST RESISTANCE; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; SPLEEN; UPREGULATION;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DISEASE SUSCEPTIBILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; IMMUNE SYSTEM; INTERFERON TYPE II; INTERLEUKIN-10; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MACROPHAGES; MICE; MICE, INBRED C57BL; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 26844535016     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-0439     Document Type: Article

References (57)

1. Vale WW, Rivier C, Perrin M, Smith M, Rivier J 1981 Pharmacology of gonadotropin releasing hormone: a model regulatory peptide. Adv Biochem Psychopharmacol 28:609-625
2. Chang CP, Pearse 2nd RV, O'Connell S, Rosenfeld MG 1993 Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron 11:1187-1195
3. Chen R, Lewis KA, Perrin MH, Vale WW 1993 Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 90:8967-8971
4. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, Oltersdorf T 1995 Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92:836-840
5. Young 3rd WS, Mezey E, Siegel RE 1986 Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci Lett 70:198-203
6. Jingami H, Matsukura S, Numa S, Imura H 1985 Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/βlipotropin precursor mRNA in the pituitary in rats. Endocrinology 117:1314-1320
7. Crofford LJ, Sano H, Karalis K, Friedman TC, Epps HR, Remmers EF, Mathern P, Chrousos GP, Wilder RL 1993 Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. J Immunol 151:1587-1596
8. Kawahito Y, Sano H, Mukai S, Asai K, Kimura S, Yamamura Y, Kato H, Chrousos GP, Wilder RL, Kondo M 1995 Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis. Gut 37:544-551
9. Scopa CD, Mastorakos G, Friedman TC, Melachrinou M, Merino MJ, Chrousos GP 1994 Presence of immunoreactive corticotropin releasing hormone in thyroid lesions. Am J Pathol 145:1159-1167
10. Challis JR, Matthews SG, Van Meir C, Ramirez MM 1995 Current topic: the placental corticotrophin-releasing hormone-adrenocorticotrophin axis. Placenta 16:481-502
11. Grino M, Chrousos GP, Margioris AN 1987 The corticotropin releasing hormone gene is expressed in human placenta. Biochem Biophys Res Commun 148:1208-1214
12. Mastorakos G, Webster EL, Friedman TC, Chrousos GP 1993 Immunoreactive corticotropin-releasing hormone and its binding sites in the rat ovary. J Clin Invest 92:961-968
13. Mastorakos G, Scopa CD, Kao LC, Vryonidou A, Friedman TC, Kattis D, Phenekos C, Rabin D, Chrousos GP 1996 Presence of immunoreactive corticotropin-releasing hormone in human endometrium. J Clin Endocrinol Metab 81:1046-1050
14. Bileviciute I, Ahmed M, Bergstrom J, Ericsson-Dahlstrand A, Kreicbergs A, Lundeberg T 1997 Expression of corticotropin-releasing factor in the peripheral nervous system of the rat. Neuroreport 8:3127-3130
15. Slominski A, Wortsman J, Pisarchik A, Zbytek B, Linton EA, Mazurkiewicz JE, Wei ET 2001 Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J 15:1678-1693
16. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, Rivier J, Sawchenko PE, Vale W 1995 Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378:287-292
17. Kishimoto T, Pearse 2nd RV, Lin CR, Rosenfeld MG 1995 A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc Natl Acad Sci USA 92:1108-1112
18. Kohno M, Kawahito Y, Tsubouchi Y, Hashiramoto A, Yamada R, Inoue KI, Kusaka Y, Kubo T, Elenkov IJ, Chrousos GP, Kondo M, Sano H 2001 Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity. J Clin Endocrinol Metab 86:4344-4352
19. Petraglia F, Florio P, Gallo R, Simoncini T, Saviozzi M, Di Blasio AM, Vaughan J, Vale W 1996 Human placenta and fetal membranes express human urocortin mRNA and peptide. J Clin Endocrinol Metab 81:3807-3810
20. Bamberger CM, Wald M, Bamberger AM, Ergun S, Beil FU, Schulte HM 1998 Human lymphocytes produce urocortin, but not corticotropin-releasing hormone. J Clin Endocrinol Metab 83:708-711
21. Slominski A, Roloff B, Curry J, Dahiya M, Szczesniewski A, Wortsman J 2000 The skin produces urocortin. J Clin Endocrinol Metab 85:815-823
22. Hsu SY, Hsueh AJ 2001 Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7:605-611
23. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE 2001 Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98:2843-2848
24. Poliak S, Mor F, Conlon P, Wong T, Ling N, Rivier J, Vale W, Steinman L 1997 Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system. J Immunol 158:5751-5756
25. Agnello D, Bertini R, Sacco S, Meazza C, Villa P, Ghezzi P 1998 Corticosteroid-independent inhibition of tumor necrosis factor production by the neuropeptide urocortin. Am J Physiol 275:E757-E762
26. Buchmeier NA, Schreiber RD 1985 Requirement of endogenous interferon-γ production for resolution of Listeria monocytogenes infection. Proc Natl Acad Sci USA 82:7404-7408
27. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547-549
28. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M 1993 Immune response in mice that lack the interferon-γ receptor. Science 259:1742-1745
29. Frei K, Nadal D, Pfister HW, Fontana A 1993 Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10. J Exp Med 178:1255-1261
30. Kelly JP, Bancroft GJ 1996 Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes. Eur J Immunol 26:356-364
31. Wagner RD, Maroushek NM, Brown JF, Czuprynski CJ 1994 Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice. Infect Immun 62:2345-2353
32. Sashinami H, Nakane A, Iwakura Y, Sasaki M 2003 Effective induction of acquired resistance to Listeria monocytogenes by immunizing mice with in vivo-infected dendritic cells. Infect Immun 71:117-125
33. Miura T, Kudo T, Matsuki A, Sekikawa K, Tagawa Y, Iwakura Y, Nakane A 2001 Effect of 6-hydroxydopamine on host resistance against Listeria monocytogenes infection. Infect Immun 69:7234-7241
34. Nakane A, Nishikawa S, Sasaki S, Miura T, Asano M, Kohanawa M, Ishiwata K, Minagawa T 1996 Endogenous interleukin-4, but not interleukin-10, is involved in suppression of host resistance against Listeria monocytogenes infection in γ interferon-depleted mice. Infect Immun 64:1252-1258
35. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
36. Shuai K, Schindler C, Prezioso VR, Darnell Jr JE 1992 Activation of transcription by IFNγ: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258:1808 -1812.
37. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I, Akira S 1999 Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10:39-49
38. Chrousos GP 1995 The hypothalamic-pituitary-adrenal axis and immunemediated inflammation. N Engl J Med 332:1351-1362
39. Fantuzzi G, Di Santo E, Sacco S, Benigni F, Ghezzi P 1995 Role of the hypothalamus-pituitary-adrenal axis in the regulation of TNF production in mice. Effect of stress and inhibition of endogenous glucocorticoids. J Immunol 155:3552-3555
40. Baigent SM 2001 Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response. Peptides 22:809-820
41. Baigent SM, Lowry PJ 2000 mRNA expression profiles for corticotrophin releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues. J Mol Endocrinol 25:43-52
42. Slominski A, Pisarchik A, Tobin DJ, Mazurkiewicz JE, Wortsman J 2004 Differential expression of a cutaneous corticotropin-releasing hormone system. Endocrinology 145:941-950
43. Tripp CS, Wolf SF, Unanue ER 1993 Interleukin 12 and tumor necrosis factor are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 90:3725-3729
44. Havell EA 1989 Evidence that tumor necrosis factor has an important role in antibacterial resistance. J Immunol 143:2894-2899
45. Nakane A, Minagawa T, Kato K 1988 Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect Immun 56:2563-2569
46. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW 1993 Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467
47. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Althage A, Zinkernagel R, Steinmetz M, Bluethmann H 1993 Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802
48. Bogdan C, Vodovotz Y, Nathan C 1991 Macrophage deactivation by interleukin 10. J Exp Med 174:1549-1555
49. Bogdan C, Rollinghoff M, Diefenbach A 2000 Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 12:64-76
50. Sato Y, Ohshima T, Kondo T 1999 Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Biochem Biophys Res Commun 265:194-199
51. Macatonia SE, Doherty TM, Knight SC, O'Garra A 1993 Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFNγ production. J Immunol 150:3755-3765
52. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M 1994 Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 179:1517-1527
53. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F 1999 An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190:995-1004
54. + cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion. J Immunol 171:2270-2278
55. Dai WJ, Kohler G, Brombacher F 1997 Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J Immunol 158:2259-2267
56. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, de Waal-Malefyt R, Ottenhoff TH 2004 Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 101:4560-4565
57. Uchiya K, Groisman EA, Nikai T 2004 Involvement of Salmonella pathogenicity island 2 in the up-regulation of interleukin-10 expression in macrophages: role of protein kinase A signal pathway. Infect Immun 72:1964-1973